Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2002
04/09/2002US6369080 Anticoagulant
04/09/2002US6369071 Treatment of angina pectoris
04/09/2002US6369069 Cardiovascular disorders
04/09/2002US6369042 Radical-scavenging functions which counteract pathophysiological disorders especially connected with aging processes; also antidotes against organophosphorous compounds; vitamin b6 antagonists; wound healing promoters
04/04/2002WO2002026731A2 Quaternary amidino based inhibitors of factor xa
04/04/2002WO2002026712A2 Quaternary amines and related inhibitors of factor xa
04/04/2002WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
04/04/2002WO2002014281A8 Pyridine derivatives as inhibitors of p38
04/04/2002WO2002008195A8 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms
04/04/2002WO2002004421A3 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
04/04/2002WO2002004407A3 7-substituted tetracycline compounds
04/04/2002WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
04/04/2002WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
04/04/2002WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists
04/04/2002WO2001081332A3 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/04/2002WO2001064643A3 Benzamides and related inhibitors of factor xa
04/04/2002US20020040148 Diphenyl heterocyclic thioamide derivatives
04/04/2002US20020040140 Crystalline therapeutic agent
04/04/2002US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example
04/04/2002US20020040036 1-(4-bromophenyl)-2-(1-methyl-2-piperidinyl)-1-ethanone, for example; treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Korsakoff's disease and frontal lobe and subcortical dementias
04/04/2002US20020040029 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
04/04/2002US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
04/04/2002US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity
04/04/2002US20020040003 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus
04/04/2002US20020039767 Batch processing using nucleophilic compound
04/04/2002DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use
04/03/2002EP1193255A1 Heterocyclic compounds and medicinal use thereof
04/03/2002EP1193254A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same
04/03/2002EP1193250A1 Phenyl sulfamate derivatives
04/03/2002EP1193246A1 Aminobenzoic acid derivatives
04/03/2002EP1192145A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
04/03/2002EP1192138A1 Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
04/03/2002EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY
04/03/2002EP1192135A2 Serine protease inhibitors
04/03/2002EP1192134A2 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol
04/03/2002EP1192132A2 Serine protease inhibitors
04/03/2002EP1192128A1 Thiol derivative, metallo-beta-lactamase inhibitors
04/03/2002EP1192127A1 Substituted benzamide inhibitors of rhinovirus 3c protease
04/03/2002EP1007512B1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
04/03/2002EP0898567B1 N-aminoalkyl-1-biphenylenyl-2-carboxamides; dopamine receptor subtype specific ligands
04/03/2002CN1342648A Process for synthesizing 2-Cl-5-trifluoromethyl pyridine
04/02/2002US6365780 Process for the preparation of aromatic or heteroaromatic sulphonyl chlorides
04/02/2002US6365744 Process for producing pyridine derivative through reaction of azametallacyclopentadiene with alkyne
04/02/2002US6365738 Reaction with hydrazine, hydroxylamine or urea. thiourea, guanidine or aniline
04/02/2002US6365690 Polymerization of ethylene
04/02/2002US6365609 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
04/02/2002US6365603 Aromatic compounds and pharmaceutical compositions containing them
04/02/2002US6365301 Delocalized nitrogen, oxygen, sulfur or phoshorous onium cation; bis-fluorosulfonimidide anion or bis-difluorophos-phonylamidide anion
04/02/2002US6365246 Package for safe storage of electrophilic fluorinating agent
04/02/2002US6365195 Fungicidal active compound combinations
04/02/2002US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
04/02/2002CA2253906C Process for preparation of pyrimidine derivatives
04/02/2002CA2178130C Method of producing 2-naphthamide derivative, and compounds for producing 2-naphthamide derivative
04/02/2002CA2038339C Herbicidal carboxamide derivatives
03/2002
03/28/2002WO2002024694A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
03/28/2002WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs
03/28/2002WO2002024688A1 2-methoxyimino-2-(pyridinyloxymethyl) phenyl acetamides useful as fungicides
03/28/2002WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY
03/28/2002WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs
03/28/2002WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
03/28/2002WO2002024636A2 N-acylsulfonamide apoptosis promoters
03/28/2002WO2002024635A2 Aminoalcohol derivatives
03/28/2002WO2002024633A1 Phenylpropionic acid derivatives
03/28/2002WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
03/28/2002WO2002024617A1 Method for the isomerisation of allyl alcohols
03/28/2002WO2002024613A2 Resorcinol derivatives
03/28/2002WO2002024194A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/28/2002WO2001097751A3 New formulation comprising a betablocker and optionally a cholesterol-lowering agent
03/28/2002WO2001083434A3 P-(sulfonyl)-aryl and heteroaryls amines
03/28/2002WO2001080844A3 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
03/28/2002US20020038030 For therapy of inflammatory conditions including migraine, rheumatoid arthritis, asthma, and inflammatory bowel disease as well as mediation of the emetic reflex and the modulation of central nervous system (CNS) disorders such as Parkinson's
03/28/2002US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes
03/28/2002US20020037909 Enamine derivatives
03/28/2002US20020037908 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating Alzheimer's disease or Creutzfelds-Jakob disease for example
03/28/2002US20020037900 Hydroxamic acid derivatives
03/28/2002US20020037896 Bicyclic compounds
03/28/2002US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth
03/28/2002US20020037885 Therapeutic compounds
03/28/2002US20020037852 Anticarcinogenic agents
03/28/2002DE10046865A1 New tungstyl peroxide complexes useful as catalysts for isomerizing allylic alcohols, e.g. geraniol
03/28/2002CA2423262A1 Resorcinol derivatives
03/28/2002CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity
03/28/2002CA2422820A1 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/28/2002CA2418046A1 Compounds having fungicidal activity and processes to make and use same
03/27/2002EP1191613A2 Luminescence device, display apparatus and metal coordination compound
03/27/2002EP1191611A2 Piezoelectric element and process for production thereof
03/27/2002EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren
03/27/2002EP1191020A2 Material for organic electroluminescence device and use thereof
03/27/2002EP1191008A1 Compound having tetrahydronaphthalene skeleton and liquid crystal composition containing the same
03/27/2002EP1190721A2 A method for the anhydrous loading of nicotine onto ion exchange resins
03/27/2002EP1189929A2 Factor viia inhibitors
03/27/2002EP1189888A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS $i(PDE 4) INHIBITORS
03/27/2002EP1189881A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
03/27/2002EP1189879A1 INHIBITORS OF FACTOR Xa
03/27/2002EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation
03/27/2002EP1189612A1 Vla-4 inhibitor compounds
03/27/2002EP1189504A1 Pyrithione biocides enhanced by silver, copper, or zinc ions
03/27/2002EP0946503B1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
03/27/2002EP0932597B1 Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
03/27/2002EP0832079B1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions